TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Clinical Trial Comparing Endovenous Laser Ablation and Mechanochemical Ablation (ClariVein®) in the Management of Superficial Venous Insufficiency
Brief Summary: A randomised clinical trial comparing endovenous laser ablation and mechanochemical ablation (ClariVein®) in the management of superficial venous insufficiency.


Options:
A: Arm Label: Surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surgery - Saphenofemoral ligation, saphenous strip and avulsions | Arm Label: EVLT; Type: EXPERIMENTAL; Interventions: Procedure: EVLT | Intervention Type: PROCEDURE; Name: Surgery - Saphenofemoral ligation, saphenous strip and avulsions; Assigned to Arm(s): Surgery | Intervention Type: PROCEDURE; Name: EVLT; Assigned to Arm(s): EVLT
B: Arm Label: EndoVenous Laser Ablation; Type: ACTIVE_COMPARATOR; Interventions: Device: EVLA, Drug: Lidocaine with 1:200,000 epinephrine solution, Drug: Sodium Bicarbonate | Arm Label: MechanoChemical Ablation (ClariVein®); Type: ACTIVE_COMPARATOR; Interventions: Device: ClariVein®, Drug: Lidocaine with 1:200,000 epinephrine solution, Drug: Sodium Tetradecyl Sulphate | Intervention Type: DEVICE; Name: EVLA; Assigned to Arm(s): EndoVenous Laser Ablation | Intervention Type: DEVICE; Name: ClariVein®; Assigned to Arm(s): MechanoChemical Ablation (ClariVein®) | Intervention Type: DRUG; Name: Lidocaine with 1:200,000 epinephrine solution; Assigned to Arm(s): EndoVenous Laser Ablation, MechanoChemical Ablation (ClariVein®) | Intervention Type: DRUG; Name: Lidocaine with 1:200,000 epinephrine solution; Assigned to Arm(s): EndoVenous Laser Ablation | Intervention Type: DRUG; Name: Sodium Bicarbonate; Assigned to Arm(s): EndoVenous Laser Ablation | Intervention Type: DRUG; Name: Sodium Tetradecyl Sulphate; Assigned to Arm(s): MechanoChemical Ablation (ClariVein®)
C: Arm Label: Experimental: VenaSeal SCS; Type: N/A; Interventions: Device: VenaSeal SCS | Arm Label: Active Comparator: RFA; Type: N/A; Interventions: Device: ClosureFast Radiofrequency Ablation (RFA) | Arm Label: Experimental: Roll-in (VenaSeal SCS); Type: N/A; Interventions: Device: Roll-In (VenaSeal SCS) | Intervention Type: DEVICE; Name: VenaSeal SCS; Assigned to Arm(s): Experimental: VenaSeal SCS | Intervention Type: DEVICE; Name: ClosureFast Radiofrequency Ablation (RFA); Assigned to Arm(s): Active Comparator: RFA | Intervention Type: DEVICE; Name: Roll-In (VenaSeal SCS); Assigned to Arm(s): Experimental: Roll-in (VenaSeal SCS)
D: Arm Label: Radiofrequency treatment; Type: EXPERIMENTAL; Interventions: Procedure: Radiofrequency ablation, Procedure: Multilayer Compressive Bandage | Arm Label: Multilayer Compressive Bandage only; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Multilayer Compressive Bandage | Intervention Type: PROCEDURE; Name: Radiofrequency ablation; Assigned to Arm(s): Radiofrequency treatment | Intervention Type: PROCEDURE; Name: Multilayer Compressive Bandage; Assigned to Arm(s): Multilayer Compressive Bandage only, Radiofrequency treatment

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Clinical Trial Comparing Endovenous Laser Ablation and Mechanochemical Ablation (ClariVein®) in the Management of Superficial Venous Insufficiency
Brief Summary: A randomised clinical trial comparing endovenous laser ablation and mechanochemical ablation (ClariVein®) in the management of superficial venous insufficiency.


Options:
A: Arm Label: high ligation and stripping; Type: ACTIVE_COMPARATOR; Interventions: Procedure: high ligation and stripping (surgery) | Arm Label: duplex guided foam sclerotherapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: FOAM | Intervention Type: PROCEDURE; Name: high ligation and stripping (surgery); Assigned to Arm(s): high ligation and stripping | Intervention Type: PROCEDURE; Name: FOAM; Assigned to Arm(s): duplex guided foam sclerotherapy
B: Arm Label: EndoVenous Laser Ablation; Type: ACTIVE_COMPARATOR; Interventions: Device: EVLA, Drug: Lidocaine with 1:200,000 epinephrine solution, Drug: Sodium Bicarbonate | Arm Label: MechanoChemical Ablation (ClariVein®); Type: ACTIVE_COMPARATOR; Interventions: Device: ClariVein®, Drug: Lidocaine with 1:200,000 epinephrine solution, Drug: Sodium Tetradecyl Sulphate | Intervention Type: DEVICE; Name: EVLA; Assigned to Arm(s): EndoVenous Laser Ablation | Intervention Type: DEVICE; Name: ClariVein®; Assigned to Arm(s): MechanoChemical Ablation (ClariVein®) | Intervention Type: DRUG; Name: Lidocaine with 1:200,000 epinephrine solution; Assigned to Arm(s): EndoVenous Laser Ablation, MechanoChemical Ablation (ClariVein®) | Intervention Type: DRUG; Name: Lidocaine with 1:200,000 epinephrine solution; Assigned to Arm(s): EndoVenous Laser Ablation | Intervention Type: DRUG; Name: Sodium Bicarbonate; Assigned to Arm(s): EndoVenous Laser Ablation | Intervention Type: DRUG; Name: Sodium Tetradecyl Sulphate; Assigned to Arm(s): MechanoChemical Ablation (ClariVein®)
C: Arm Label: Endovenous laser ablation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Endovenous laser ablation with 940 nm bare fiber | Arm Label: Endovenous steam ablation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Endovenous steam ablation with steam vein sclerosis system. | Intervention Type: PROCEDURE; Name: Endovenous laser ablation with 940 nm bare fiber; Assigned to Arm(s): Endovenous laser ablation | Intervention Type: PROCEDURE; Name: Endovenous steam ablation with steam vein sclerosis system.; Assigned to Arm(s): Endovenous steam ablation
D: Arm Label: CE Marked Sapheon Closure System in GSV; Type: EXPERIMENTAL; Interventions: Device: CE Marked Sapheon Closure System | Intervention Type: DEVICE; Name: CE Marked Sapheon Closure System; Assigned to Arm(s): CE Marked Sapheon Closure System in GSV

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Single Center, Prospective, Randomized, Double Blind, Placebo-controlled, Three-way Cross-over Study of the Analgesic Effects of Midazolam Versus Placebo With Fentanyl as an Active Control in Human Volunteers
Brief Summary: This study evaluates analgesic properties of midazolam compared to placebo and fentanyl. Each participant will receive all three drugs (midazolam, fentanyl, placebo) on three different occasions (study visits) and the effect on different pain stimuli will be tested.


Options:
A: Arm Label: Placebo First, then ORADUR®; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo First, then ORADUR® | Arm Label: ORADUR® First, then Placebo; Type: EXPERIMENTAL; Interventions: Drug: ORADUR® First, then Placebo | Intervention Type: DRUG; Name: Placebo First, then ORADUR®; Assigned to Arm(s): Placebo First, then ORADUR® | Intervention Type: DRUG; Name: ORADUR® First, then Placebo; Assigned to Arm(s): ORADUR® First, then Placebo
B: Arm Label: Cannabis oil high dose; Type: EXPERIMENTAL; Interventions: Drug: Tetrahydrocannabinol | Arm Label: Cannabis oil low dose; Type: EXPERIMENTAL; Interventions: Drug: Tetrahydrocannabinol | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Dummy oromucosal | Intervention Type: DRUG; Name: Tetrahydrocannabinol; Assigned to Arm(s): Cannabis oil high dose, Cannabis oil low dose | Intervention Type: DRUG; Name: Dummy oromucosal; Assigned to Arm(s): Control
C: Arm Label: Methylphenidate Transdermal System; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methylphenidate Transdermal System | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Concerta; Type: ACTIVE_COMPARATOR; Interventions: Drug: Concerta | Intervention Type: DRUG; Name: Methylphenidate Transdermal System; Assigned to Arm(s): Methylphenidate Transdermal System | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Concerta; Assigned to Arm(s): Concerta
D: Arm Label: Midazolam; Type: EXPERIMENTAL; Interventions: Drug: Midazolam | Arm Label: Isotonic saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Isotonic saline | Arm Label: Fentanyl; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fentanyl | Intervention Type: DRUG; Name: Midazolam; Assigned to Arm(s): Midazolam | Intervention Type: DRUG; Name: Fentanyl; Assigned to Arm(s): Fentanyl | Intervention Type: DRUG; Name: Isotonic saline; Assigned to Arm(s): Isotonic saline

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Double-blinded, Active-controlled 2-way Cross Over Trial to Assess the Effects of 6 Weeks Treatment of Once Daily Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination Delivered by RESPIMAT Inhaler Compared With Tiotropium Delivered by RESPIMAT Inhaler on Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)
Brief Summary: This is a multi-centre, randomised, double-blinded, active-controlled, 2-way cross over trial to assess the effects of once daily administration of orally inhaled tiotropium + olodaterol FDC or tiotropium (both delivered by the RESPIMAT Inhaler) on pulmonary function (lung hyperinflation), exercise capacity (6-minute walk distance) and physical activities after 6 weeks of treatment in Japanese patients with Chronic Obstructive Pulmonary Disease.


Options:
A: Arm Label: Exercise intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise intervention
B: Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supervised COPD Rehabilitation (control group) | Arm Label: Online COPD rehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Online COPD rehabilitation (experimental) | Intervention Type: BEHAVIORAL; Name: Supervised COPD Rehabilitation (control group); Assigned to Arm(s): Control group | Intervention Type: BEHAVIORAL; Name: Online COPD rehabilitation (experimental); Assigned to Arm(s): Online COPD rehabilitation
C: Arm Label: tiotropium + olodaterol; Type: EXPERIMENTAL; Interventions: Drug: tiotropium, Drug: olodaterol | Arm Label: tiotropium; Type: ACTIVE_COMPARATOR; Interventions: Drug: tiotropium | Intervention Type: DRUG; Name: tiotropium; Assigned to Arm(s): tiotropium + olodaterol | Intervention Type: DRUG; Name: olodaterol; Assigned to Arm(s): tiotropium + olodaterol | Intervention Type: DRUG; Name: tiotropium; Assigned to Arm(s): tiotropium
D: Arm Label: Aclidinium bromide; Type: EXPERIMENTAL; Interventions: Drug: Aclidinium Bromide | Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Aclidinium Bromide; Assigned to Arm(s): Aclidinium bromide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Community-based Model of Delivery of Kangaroo Mother Care for Improving Child Survival and Brain Development in Low Birth Weight Newborns
Brief Summary: While newborn and child survival remains a priority, optimal development of survivors is receiving increasing attention. Interventions that impact both survival and development should be prioritized for action. Kangaroo Mother Care (KMC) improves survival, and potentially neurodevelopment, in preterm and low birth weight infants in hospital settings but its coverage remains low. Innovation is required to allow the community-based delivery of KMC by front-line workers. This could greatly accelerate scale up and sustainability of this intervention in low resource settings.

The proposed randomized trial is planned in a setting where 40% of births take place at home. Early discharge (as early as within 12 hours of birth) is common for facility births, often at the request of families for social and cultural reasons. Many of the hospitals do not have incubators for the care of very small babies.


Options:
A: Arm Label: Home Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Home based, flexible, stepped care intervention | Arm Label: Wait-list; Type: OTHER; Interventions: Behavioral: Home based, flexible, stepped care intervention after 6 months. Families will be free to choose any health care they desire during the waiting period. | Intervention Type: BEHAVIORAL; Name: Home based, flexible, stepped care intervention; Assigned to Arm(s): Home Care | Intervention Type: BEHAVIORAL; Name: Home based, flexible, stepped care intervention after 6 months. Families will be free to choose any health care they desire during the waiting period.; Assigned to Arm(s): Wait-list
B: Arm Label: Intervention KMC; Type: EXPERIMENTAL; Interventions: Behavioral: KMC, Other: Essential newborn care | Arm Label: Control; Type: OTHER; Interventions: Other: Essential newborn care | Intervention Type: BEHAVIORAL; Name: KMC; Assigned to Arm(s): Intervention KMC | Intervention Type: OTHER; Name: Essential newborn care; Assigned to Arm(s): Control, Intervention KMC
C: Arm Label: Maternal support to become mother; Type: EXPERIMENTAL; Interventions: Behavioral: Maternal support to become mother | Arm Label: Control group: usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control Group: usual care | Intervention Type: BEHAVIORAL; Name: Maternal support to become mother; Assigned to Arm(s): Maternal support to become mother | Intervention Type: BEHAVIORAL; Name: Control Group: usual care; Assigned to Arm(s): Control group: usual Care
D: Arm Label: Intervention Kangaroo Mother Care; Type: EXPERIMENTAL; Interventions: Behavioral: Kangaroo Mother Care | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Kangaroo Mother Care; Assigned to Arm(s): Intervention Kangaroo Mother Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Dietary Intervention Examining Tracking With Mobile Devices Study
Brief Summary: The purpose of the study is to test the effectiveness of two different weight loss interventions. Both of these interventions will provide weight loss information through twice weekly audio podcasts. In addition to the podcasts, participants will be asked to track their diet using either a wearable device on their wrist or through an app on their smartphone.


Options:
A: Arm Label: Podcast (+Bite Counter); Type: EXPERIMENTAL; Interventions: Behavioral: Podcasts, Behavioral: Bite Counter | Arm Label: Podcast (+Mobile App); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Podcasts, Behavioral: Mobile Diet Application | Intervention Type: BEHAVIORAL; Name: Podcasts; Assigned to Arm(s): Podcast (+Bite Counter), Podcast (+Mobile App) | Intervention Type: BEHAVIORAL; Name: Mobile Diet Application; Assigned to Arm(s): Podcast (+Mobile App) | Intervention Type: BEHAVIORAL; Name: Bite Counter; Assigned to Arm(s): Podcast (+Bite Counter)
B: Arm Label: Simple; Type: EXPERIMENTAL; Interventions: Behavioral: Simple | Arm Label: Standard; Type: EXPERIMENTAL; Interventions: Behavioral: Standard | Intervention Type: BEHAVIORAL; Name: Simple; Assigned to Arm(s): Simple | Intervention Type: BEHAVIORAL; Name: Standard; Assigned to Arm(s): Standard
C: Arm Label: Sequential Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: self-monitoring of body weight, Behavioral: self-monitoring of diet, Behavioral: weekly personalized feedback + lessons + action plans | Arm Label: Simultaneous Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: self-monitoring of body weight, Behavioral: self-monitoring of diet, Behavioral: weekly personalized feedback + lessons + action plans | Arm Label: Control (diet-tracking only); Type: EXPERIMENTAL; Interventions: Behavioral: self-monitoring of diet | Intervention Type: BEHAVIORAL; Name: self-monitoring of body weight; Assigned to Arm(s): Sequential Intervention, Simultaneous Intervention | Intervention Type: BEHAVIORAL; Name: self-monitoring of diet; Assigned to Arm(s): Control (diet-tracking only), Sequential Intervention, Simultaneous Intervention | Intervention Type: BEHAVIORAL; Name: weekly personalized feedback + lessons + action plans; Assigned to Arm(s): Sequential Intervention, Simultaneous Intervention
D: Arm Label: Treatment One; Type: EXPERIMENTAL; Interventions: Behavioral: SMART 2.0 | Arm Label: Treatment Two; Type: EXPERIMENTAL; Interventions: Behavioral: SMART 2.0 | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SMART 2.0; Assigned to Arm(s): Treatment One, Treatment Two

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Malezi ne Kilimo Bora (Good Parenting and Farming) - Skilful Parenting and Agribusiness Child Abuse Prevention Study (SPACAPS)
Brief Summary: The Malezi ne Kilimo Bora ("Good Parenting and Farming" in Kiswahili) Skilful Parenting and Agribusiness Child Abuse Prevention Study is a collaboration between the University of Oxford, University of Glasgow, and the Tanzania National Medical Research Institute (NIMR). It is pilot cluster randomised controlled trial (cRCT) of a community-based intervention implemented by Investing in Children and Our Societies (ICS), an international non-governmental organization (NGO) with extensive experience operating in rural Tanzania. The overall focus of the project is to evaluate ICS's agribusiness and skilful parenting programmes' impact on the prevention of child maltreatment and improvement of child and family psychosocial and economic wellbeing (n = 8 villages, n = 16 farmer groups, n = 240 families).


Options:
A: Arm Label: Specialty Care; Type: ACTIVE_COMPARATOR; Interventions: Other: psychiatric medications and evidence-based psychotherapies | Arm Label: Integrated Care; Type: EXPERIMENTAL; Interventions: Other: psychiatric medications and evidence-based psychotherapies | Arm Label: Community Clinic Stepped Care; Type: EXPERIMENTAL; Interventions: Other: psychiatric medications and evidence-based psychotherapies | Intervention Type: OTHER; Name: psychiatric medications and evidence-based psychotherapies; Assigned to Arm(s): Community Clinic Stepped Care, Integrated Care, Specialty Care
B: Arm Label: Brief Intervention (BI); Type: EXPERIMENTAL; Interventions: Behavioral: Brief Intervention | Arm Label: Brief Intervention + CETA; Type: EXPERIMENTAL; Interventions: Behavioral: Brief Intervention, Behavioral: Common Elements Treatment Approach (CETA) | Intervention Type: BEHAVIORAL; Name: Brief Intervention; Assigned to Arm(s): Brief Intervention (BI), Brief Intervention + CETA | Intervention Type: BEHAVIORAL; Name: Common Elements Treatment Approach (CETA); Assigned to Arm(s): Brief Intervention + CETA
C: Arm Label: Parenting Training; Type: EXPERIMENTAL; Interventions: Behavioral: Skilful Parenting | Arm Label: Agricultural Training; Type: EXPERIMENTAL; Interventions: Other: Agrics | Arm Label: Parenting and Agricultural Training; Type: EXPERIMENTAL; Interventions: Behavioral: Skilful Parenting, Other: Agrics | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Skilful Parenting; Assigned to Arm(s): Parenting Training, Parenting and Agricultural Training | Intervention Type: OTHER; Name: Agrics; Assigned to Arm(s): Agricultural Training, Parenting and Agricultural Training
D: Arm Label: Early Childhood Development Program; Type: EXPERIMENTAL; Interventions: Behavioral: Early Childhood Development Program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Early Childhood Development Program; Assigned to Arm(s): Early Childhood Development Program

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3 Open Label Study to Evaluate the Long-term Safety and Tolerability of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis
Brief Summary: The primary objective of this study is to evaluate the long-term safety and tolerability of ALKS 8700 for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS). The secondary objective of this study is to evaluate treatment effect over time in adult participants with RRMS treated with ALKS 8700.


Options:
A: Arm Label: ALKS 8700; Type: EXPERIMENTAL; Interventions: Drug: ALKS 8700 | Intervention Type: DRUG; Name: ALKS 8700; Assigned to Arm(s): ALKS 8700
B: Intervention Type: DRUG; Name: Daclizumab (Anti-CD25 Humanized Monoclonal Antibody); Assigned to Arm(s): N/A
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: BIIB017 (peginterferon beta-1a), Drug: Placebo | Arm Label: Peginterferon Beta-1a Q2W; Type: EXPERIMENTAL; Interventions: Drug: BIIB017 (peginterferon beta-1a) | Arm Label: Peginterferon Beta-1a Q4W; Type: EXPERIMENTAL; Interventions: Drug: BIIB017 (peginterferon beta-1a), Drug: Placebo | Intervention Type: DRUG; Name: BIIB017 (peginterferon beta-1a); Assigned to Arm(s): Peginterferon Beta-1a Q2W, Peginterferon Beta-1a Q4W, Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Peginterferon Beta-1a Q4W, Placebo
D: Arm Label: Interferon beta-1a; Type: ACTIVE_COMPARATOR; Interventions: Drug: Interferon beta-1a, Drug: Placebo to ozanimod | Arm Label: Ozanimod 0.5 mg; Type: EXPERIMENTAL; Interventions: Drug: Ozanimod, Drug: Placebo to interferon beta-1a | Arm Label: Ozanimod 1 mg; Type: EXPERIMENTAL; Interventions: Drug: Ozanimod, Drug: Placebo to interferon beta-1a | Intervention Type: DRUG; Name: Ozanimod; Assigned to Arm(s): Ozanimod 0.5 mg, Ozanimod 1 mg | Intervention Type: DRUG; Name: Interferon beta-1a; Assigned to Arm(s): Interferon beta-1a | Intervention Type: DRUG; Name: Placebo to ozanimod; Assigned to Arm(s): Interferon beta-1a | Intervention Type: DRUG; Name: Placebo to interferon beta-1a; Assigned to Arm(s): Ozanimod 0.5 mg, Ozanimod 1 mg

Answer: A